{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:01:34Z","timestamp":1790845294688,"version":"4.1.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100014269","name":"Uniwersytet Medyczny w Bia\u0142ymstoku","doi-asserted-by":"publisher","award":["B.SUB.26.152"],"award-info":[{"award-number":["B.SUB.26.152"]}],"id":[{"id":"10.13039\/501100014269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004442","name":"Narodowym Centrum Nauki","doi-asserted-by":"publisher","award":["2021\/43\/B\/NZ7\/01903"],"award-info":[{"award-number":["2021\/43\/B\/NZ7\/01903"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12848-x","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:42:03Z","timestamp":1790844123000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Platelet activation and eicosanoid signaling in ovarian cancer: implications for biomarker development"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5602-0868","authenticated-orcid":false,"given":"Joanna","family":"Kirmu\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3401-2758","authenticated-orcid":false,"given":"Marcin","family":"J\u00f3\u017awik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4130-349X","authenticated-orcid":false,"given":"Karol","family":"Kramkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"12848_CR1","doi-asserted-by":"publisher","unstructured":"Sung H, Ferlay J, Siegel RL et al (2026) Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries. CA Cancer J Clin 76(4):e70090. https:\/\/doi.org\/10.3322\/caac.70090","DOI":"10.3322\/caac.70090"},{"key":"12848_CR2","unstructured":"Krajowy Rejestr Nowotwor\u00f3w (2026) Raporty i statystyki \u2013 zachorowania i zgony z powodu nowotwor\u00f3w z\u0142o\u015bliwych w Polsce. Narodowy Instytut Onkologii im. Marii Sk\u0142odowskiej-Curie \u2013 Pa\u0144stwowy Instytut Badawczy. Available from: https:\/\/onkologia.org.pl\/pl\/raporty. Accessed July 28"},{"issue":"4","key":"12848_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2174\/1568026620999201111155426","volume":"21","author":"B Shaik","year":"2021","unstructured":"Shaik B, Zafar T, Balasubramanian K, Gupta SP (2021) An overview of ovarian cancer: molecular processes involved and development of target-based chemotherapeutics. Curr Top Med Chem 21(4):329\u2013346. https:\/\/doi.org\/10.2174\/1568026620999201111155426","journal-title":"Curr Top Med Chem"},{"key":"12848_CR4","doi-asserted-by":"publisher","DOI":"10.1787\/aab579a7-pl","author":"OECD","year":"2023","unstructured":"OECD (2023) Krajowe profile dotycz\u0105ce nowotwor\u00f3w: Polska 2023. EU Country Cancer Profiles Paris: OECD Publishing. https:\/\/doi.org\/10.1787\/aab579a7-pl","journal-title":"EU Country Cancer Profiles Paris: OECD Publishing"},{"issue":"2","key":"12848_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.5114\/pm.2023.128661","volume":"22","author":"AT Ali","year":"2023","unstructured":"Ali AT, Al-ani O, Al-ani F (2023) Epidemiology and risk factors for ovarian cancer. Menopause Rev 22(2):93\u2013104. https:\/\/doi.org\/10.5114\/pm.2023.128661","journal-title":"Menopause Rev"},{"key":"12848_CR6","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/S1470-2045(24)00406-6","volume":"10","author":"S Sundar","year":"2024","unstructured":"Sundar S, Agarwal R, Davenport C, Scandrett K, Johnson S, Sengupta P, Selvi-Vikram R, Kwong FL, Mallett S, Rick C, Kehoe S, Timmerman D, Bourne T, Van Calster B, Stobart H, Neal RD, Menon U, Gentry-Maharaj A, Sturdy L, Ottridge R, Deeks J (2024) ROCkeTS collaborators. Risk-prediction model in postmenopausal patients with symptoms of suspected ovarian cancer in the UK (ROCkeTS): a multicentre, prospective diagnostic accuracy study. Lancet Oncol 10:1371\u20131386. https:\/\/doi.org\/10.1016\/S1470-2045(24)00406-6","journal-title":"Lancet Oncol"},{"issue":"11","key":"12848_CR7","doi-asserted-by":"publisher","first-page":"868","DOI":"10.5306\/wjco.v11.i11.868","volume":"11","author":"L Feeney","year":"2020","unstructured":"Feeney L, Harley IJG, McCluggage WG, Mullan PB, Beirne J (2020) Liquid biopsy in ovarian cancer: catching the silent killer before it strikes. World J Clin Oncol 11(11):868\u2013889. https:\/\/doi.org\/10.5306\/wjco.v11.i11.868","journal-title":"World J Clin Oncol"},{"issue":"6","key":"12848_CR8","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1136\/ijgc-2020-001231","volume":"30","author":"SN Koole","year":"2020","unstructured":"Koole SN, van Stein RM, Sikorska K, Bartom DP, Perrin L et al (2020) Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial. Int J Gynecol Cancer 30(6):888\u2013892. https:\/\/doi.org\/10.1136\/ijgc-2020-001231","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"12848_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/gco.0000000000000340","volume":"29","author":"PT Kroeger Jr","year":"2017","unstructured":"Kroeger PT Jr, Drapkin R (2017) Pathogenesis and heterogeneity of ovarian cancer. Gynecol Oncol 29(1):26\u201334. https:\/\/doi.org\/10.1097\/gco.0000000000000340","journal-title":"Gynecol Oncol"},{"key":"12848_CR10","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.2214\/AJR.15.15199","volume":"206","author":"DM Javadi Sanaz, Ganeshan","year":"2016","unstructured":"Javadi Sanaz, Ganeshan DM, Qayyum A, Iyer RB, Bhosale P (2016) Ovarian Cancer, the revised FIGO staging system and role of imaging. Am J Roentgenol 206:1351\u20131360. https:\/\/doi.org\/10.2214\/AJR.15.15199","journal-title":"Am J Roentgenol"},{"key":"12848_CR11","unstructured":"Arora T, Mullangi S, Vadekekut ES, Lekkala ML (2024) Epithelial ovarian cancer. In: StatPearls. Treasure Island (FL): StatPearls Publishing; Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK567760\/"},{"issue":"1\u20132","key":"12848_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000479006","volume":"85","author":"M Kossai","year":"2018","unstructured":"Kossai M, Leary A, Scoazec JY, Genestie C (2018) Ovarian cancer: a heterogeneous disease. Pathobiology 85(1\u20132):41\u201349. https:\/\/doi.org\/10.1159\/000479006","journal-title":"Pathobiology"},{"key":"12848_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ejcsup.2019.12.001","volume":"15","author":"R Lopez-Reig","year":"2020","unstructured":"Lopez-Reig R, Lopez-Guerrero JA (2020) The hallmarks of ovarian cancer: proliferation and cell growth. Eur J Cancer Suppl 15:27\u201337. https:\/\/doi.org\/10.1016\/j.ejcsup.2019.12.001","journal-title":"Eur J Cancer Suppl"},{"key":"12848_CR14","doi-asserted-by":"publisher","first-page":"104456","DOI":"10.1016\/j.critrevonc.2024.104465","volume":"202","author":"Q Xie","year":"2024","unstructured":"Xie Q, Zhou J, He C, Xu Y, Tao F, Hu M (2024) Unlocking the intricacies: Exploring the complex interplay between platelets and ovarian cancer. Crit Rev Oncol\/Hematol 202:104456. https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104465","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"12848_CR15","doi-asserted-by":"publisher","first-page":"1381894","DOI":"10.3389\/fonc.2024.1381894","volume":"14","author":"Q Xia","year":"2024","unstructured":"Xia Q, Gao W, Yang J, Xing Z, Ji Z (2024) The dysregulation of arachidonic acid metabolism in ovarian cancer. Front Oncol 14:1381894. https:\/\/doi.org\/10.3389\/fonc.2024.1381894","journal-title":"Front Oncol"},{"issue":"8","key":"12848_CR16","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/bph.14196","volume":"176","author":"M Crescente","year":"2019","unstructured":"Crescente M, Menke L, Chan MV, Armstrong PC, Warner TD (2019) Eicosanoids in platelets and the effect of their modulation by aspirin in the cardiovascular system and beyond. Br J Pharmacol 176(8):988\u2013999. https:\/\/doi.org\/10.1111\/bph.14196","journal-title":"Br J Pharmacol"},{"issue":"3","key":"12848_CR17","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.ygyno.2017.02.033","volume":"145","author":"GM Saed","year":"2017","unstructured":"Saed GM, Diamond MP, Flechter NM (2017) Updates of the role of oxidative stress in the pathogenesis of ovarian cancer. Gynecol Oncol 145(3):595\u2013602. https:\/\/doi.org\/10.1016\/j.ygyno.2017.02.033","journal-title":"Gynecol Oncol"},{"key":"12848_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/149185","volume":"149185","author":"G Landskron","year":"2014","unstructured":"Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA (2014) Chronic inflammation and cytokinesis in the tumor microenviroment. J Immunol Res 149185:1\u201319. https:\/\/doi.org\/10.1155\/2014\/149185","journal-title":"J Immunol Res"},{"issue":"18","key":"12848_CR19","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.2174\/1381612827666210303143442","volume":"27","author":"LJB Malhab","year":"2021","unstructured":"Malhab LJB, Saber-Ayad M, Al-Hakm R, Nair VA, Paliogiannis P et al (2021) Chronic inflammation and cancer: the role of endothelial dysfunction and vascular inflammation. Curr Pharm Design 27(18):2156\u20132169. https:\/\/doi.org\/10.2174\/1381612827666210303143442","journal-title":"Curr Pharm Design"},{"key":"12848_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41571-020-00459-9","volume":"18","author":"J Hou","year":"2021","unstructured":"Hou J, Karin M, Sun B (2021) Targeting cancer-promoting inflammation \u2013 have anti-inflammatory therapies come of age? Nat Reviews Clin Oncol 18:261\u2013279. https:\/\/doi.org\/10.1038\/s41571-020-00459-9","journal-title":"Nat Reviews Clin Oncol"},{"key":"12848_CR21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3390\/antiox14010114","volume":"14","author":"Y Long","year":"2025","unstructured":"Long Y, Shi H, Ye J, Qi X (2025) Exploring strategies to prevent and treat ovarian cancer in terms of oxidative stress and antioxidants. Antioxidants 14:114. https:\/\/doi.org\/10.3390\/antiox14010114","journal-title":"Antioxidants"},{"issue":"8","key":"12848_CR22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/cancers10080251","volume":"10","author":"S Savant","year":"2018","unstructured":"Savant S, Sriramkumar S, O\u2019Hagan HM (2018) The role of inflammation and inflammatory mediators in the development, progression, metastasis and chemoresistance of epithelial ovarian cancer. Cancers 10(8):251. https:\/\/doi.org\/10.3390\/cancers10080251","journal-title":"Cancers"},{"issue":"10","key":"12848_CR23","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1111\/cas.15068","volume":"112","author":"H Nakamura","year":"2021","unstructured":"Nakamura H, Takada K (2021) Reactive oxygen species in cancer: current findings and future directions. Cancer Sci 112(10):3945\u20133952. https:\/\/doi.org\/10.1111\/cas.15068","journal-title":"Cancer Sci"},{"issue":"1","key":"12848_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/aje\/kww161","volume":"185","author":"CB Rasmussen","year":"2016","unstructured":"Rasmussen CB, Kjaer SK, Albieri V, Bandera EV, Doherty JA et al (2016) Pelvic inflammatory disease and the risk of ovarian cancer and borderline ovarian tumors: a pooled analysis of 13 case-control studies. Am J Epidemiol 185(1):8\u201320. https:\/\/doi.org\/10.1093\/aje\/kww161","journal-title":"Am J Epidemiol"},{"key":"12848_CR25","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.3906\/sag-2007-254","volume":"51","author":"F Erten","year":"2021","unstructured":"Erten F, Yenice E, Orhan C, Er B, Demirel Oner P, Defo Deeh PB, Sahin K (2021) Ganistei suppresses the inflammation and GSK-3 pathway in an animal model of spontaneous ovarian cancer. Turk J Med Sci 51:1465\u20131471. https:\/\/doi.org\/10.3906\/sag-2007-254","journal-title":"Turk J Med Sci"},{"key":"12848_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13048-022-01084-z","volume":"16","author":"J Yu Liang, Sun","year":"2023","unstructured":"Yu Liang, Sun J, Wang Q, Yu W, Wang A, Zhu S, Xu W, Wang X (2023) Ovulation introductiondrug and ovarian cancer: an updated systematic review and meta-analysis. J Ovarian Res 16:22. https:\/\/doi.org\/10.1186\/s13048-022-01084-z","journal-title":"J Ovarian Res"},{"key":"12848_CR27","doi-asserted-by":"publisher","unstructured":"Mitchell JA, Kirkby NS (2019) Eicosanoids, prostacyclin and cyclooxygenase in the cardiovascular system. British Journal of Pharmacology 176(8):1038\u20131050. https:\/\/doi.org\/10.1111\/bph.14167","DOI":"10.1111\/bph.14167"},{"key":"12848_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13048-021-00772-6","volume":"14","author":"A Maccio","year":"2021","unstructured":"Maccio A, Oppi S, Madeddu C (2021) COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied? J Ovarian Reserach 14:28. https:\/\/doi.org\/10.1186\/s13048-021-00772-6","journal-title":"J Ovarian Reserach"},{"key":"12848_CR29","doi-asserted-by":"publisher","first-page":"4187","DOI":"10.3390\/cancers16244187","volume":"16","author":"H Amer","year":"2024","unstructured":"Amer H, Kampan NC, Itsiopoulos C, Flanagan KL, Scott CL, Kartikasari AER, Plebanski M (2024) Interleukin-6 Modulation in Ovarian Cancer Necessitates a Targeted Strategy: From the Approved to Emerging Strategies. Cancers 16:4187. https:\/\/doi.org\/10.3390\/cancers16244187","journal-title":"Cancers"},{"key":"12848_CR30","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3390\/cancers15041282","volume":"15","author":"S Oncul","year":"2023","unstructured":"Oncul S, Cho MS (2023) Interactions between platelets and tumor microenvironment components in ovarian cancer and their implications for treatment and clinical outcomes. Cancers 15:1282. https:\/\/doi.org\/10.3390\/cancers15041282","journal-title":"Cancers"},{"key":"12848_CR31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10555-018-9750-0","volume":"37","author":"AA Panagiotopoulos","year":"2018","unstructured":"Panagiotopoulos AA, Kalyvianaki K, Castanas E, Kampa M (2018) Eicosanoids in prostate cancer. Cancer Metastasis Rev 37:237\u2013243. https:\/\/doi.org\/10.1007\/s10555-018-9750-0","journal-title":"Cancer Metastasis Rev"},{"issue":"12","key":"12848_CR32","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.3390\/life14121630","volume":"14","author":"I Guerra de Melo","year":"2024","unstructured":"Guerra de Melo I, Tavares V, Savva-Bordalo J, Rei M, Liz-Pimenta J, Pereira D, Medeiros R (2024) Endothelial dysfunction markers in ovarian cancer: VTE risk and tumor prognostic outcomes. Life 14(12):1630. https:\/\/doi.org\/10.3390\/life14121630","journal-title":"Life"},{"key":"12848_CR33","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12885-015-1304-z","volume":"15","author":"R Orellana","year":"2015","unstructured":"Orellana R, Kato S, Erices R, Bravo ML, Gonzalez P et al (2015) Platelets enhance tissue factor protein and metastasis initiating the migration of ovarian cancer cells. BMC Cancer 15:290. https:\/\/doi.org\/10.1186\/s12885-015-1304-z","journal-title":"BMC Cancer"},{"key":"12848_CR34","doi-asserted-by":"publisher","first-page":"100109","DOI":"10.1016\/j.pharmr.2025.100109","volume":"78","author":"C Patrono","year":"2025","unstructured":"Patrono C, Burn J, Patrignani, Langley R (2025) Platelet activation, aspirin, and cancer: From basic science to clinical trials. Pharmacol Rev 78:100109. https:\/\/doi.org\/10.1016\/j.pharmr.2025.100109","journal-title":"Pharmacol Rev"},{"key":"12848_CR35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40981-020-00339-2","volume":"6","author":"Y Watanabe","year":"2020","unstructured":"Watanabe Y, Matsunuma K, Kaneda T (2020) A case of successful anesthetic management in a patient with Trousseau\u2019s syndrome who underwent surgery for malignant ovarian tumor. J Anesth Clin Rep 6:32. https:\/\/doi.org\/10.1186\/s40981-020-00339-2","journal-title":"J Anesth Clin Rep"},{"key":"12848_CR36","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12185-024-03735-x","volume":"119","author":"K Tatsui","year":"2024","unstructured":"Tatsui K (2024) The pathogenesis of cancer-associated thrombosis. Int J Hematol 119:495\u2013504. https:\/\/doi.org\/10.1007\/s12185-024-03735-x","journal-title":"Int J Hematol"},{"key":"12848_CR37","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s43856-025-01240-8","volume":"5","author":"V Raparelli","year":"2025","unstructured":"Raparelli V, Miglionico M, Maiorca F, Napoleone L, Ludovica L, Sabetta A, D\u2019Amico T, Romiti GF, Lenzi A, Nocella C, D\u2019Amico A, Frati G, Sciaretta S, Carnevale R, Cangemi R, Basili S, Stefanini L (2025) Changes of in-vivo markers of platelet activation during the menstrual cycle in healthy pre-menopausal female individuals. Commun Med 5:533. https:\/\/doi.org\/10.1038\/s43856-025-01240-8","journal-title":"Commun Med"},{"key":"12848_CR38","doi-asserted-by":"publisher","first-page":"102623","DOI":"10.1016\/j.rpth.2024.102623","volume":"8","author":"G Petrucci","year":"2024","unstructured":"Petrucci G, Rizzi A, Bellavia S, Dentali F, Frisullo G, Pitocco D, Ranalli P, Rizzo PA, Scala I, Silingardi M, Zagarri E, Gussoni G, Rocca B (2024) Stability of the thromboxane B2 biomarkker of low-doce aspirin pharmacodynamics in human whole blood and in long-term stored serum samples. Res Pract Thromb Haemostasis 8:102623. https:\/\/doi.org\/10.1016\/j.rpth.2024.102623","journal-title":"Res Pract Thromb Haemostasis"},{"key":"12848_CR39","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1093\/carcin\/7.7.1051","volume":"7","author":"H Sundstrom","year":"1984","unstructured":"Sundstrom H, Ylikorkala O, Kauppilla A (1984) Serum selenium and thromboxane in patients with gynecological cancer. Carcinogenesis 7:1051\u20131052. https:\/\/doi.org\/10.1093\/carcin\/7.7.1051","journal-title":"Carcinogenesis"},{"key":"12848_CR40","first-page":"2396","volume":"48","author":"AM Aitokallio-Tallberg","year":"1988","unstructured":"Aitokallio-Tallberg AM, Viinikka LU, Ylikokrala RO (1988) Increased synthesis of prostacyclin and thromboxane in human ovarian malignancy. Cancer Res 48:2396\u20132398","journal-title":"Cancer Res"},{"key":"12848_CR41","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","volume":"6","author":"B Wang","year":"2021","unstructured":"Wang B, Wu L, Chen J, Dong L, Chen C et al (2021) Metabolism pathways of AA: mechanisms and potential therapeutic targets. Signal Transduct Target Therapy 6:94. https:\/\/doi.org\/10.1038\/s41392-020-00443-w","journal-title":"Signal Transduct Target Therapy"},{"key":"12848_CR42","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.biocel.2017.05.022","volume":"89","author":"A Colquhoun","year":"2017","unstructured":"Colquhoun A (2017) Cell biology-metabolomic crosstalk in glioma. Int J Biochem Cell Biology 89:171\u2013181. https:\/\/doi.org\/10.1016\/j.biocel.2017.05.022","journal-title":"Int J Biochem Cell Biology"},{"key":"12848_CR43","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12917-016-0738-0","volume":"12","author":"N Ma","year":"2016","unstructured":"Ma N, Liu X, Yang Y, Shen D, Zhao X, Mohamed I, Kong X, Li J (2016) Evaluation on antithrombotic effect of aspirin eugenol ester from the view of platelet aggregation, hemorheology, TXB2\/6-keto PGF1? and blood biochemistry in rat model. BMC Vet Res 12:108. https:\/\/doi.org\/10.1186\/s12917-016-0738-0","journal-title":"BMC Vet Res"},{"key":"12848_CR44","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/jth.13667","volume":"15","author":"JS Paikin","year":"2017","unstructured":"Paikin JS, Hirsh J, Ginsberg JS, Weitz JI, Chan NC, Whitloc RP, Paree G, Eikelboom JW (2017) Once versus twice daily aspirin after coronary bypass surgery: a randomized trial. J Thromb Haemost 15:889\u2013896. https:\/\/doi.org\/10.1111\/jth.13667","journal-title":"J Thromb Haemost"},{"key":"12848_CR45","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1513\/AnnalsATS.202311-955OC","volume":"21","author":"MH Ryu","year":"2024","unstructured":"Ryu MH, Hur SA, Afshar T, Kolmert J, Zurita J, Wheelock CE, Carlsten C (2024) Impact of short-term diesel exhaust exposure on prothrombotic markers in chronic obstructive pulmonary disease: A randomized double-blind, crossover study. Annals Am Thorac Soc 21:1715\u20131722. https:\/\/doi.org\/10.1513\/AnnalsATS.202311-955OC","journal-title":"Annals Am Thorac Soc"},{"key":"12848_CR46","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1158\/2767-9764.CRC-25-0140","volume":"5","author":"BM Giles","year":"2025","unstructured":"Giles BM, Culp-Hill R, Law RA, Nichols CM, Goldberg M, Radnaa E, Wong M, Hansen C, Zapata M, Hill C, Behbakht K, Bitler BG, Crosbie EJ, Barr CE, Jeter A, Fa VS, Guthrie VB, Hagmann LN, Kubota EC, White JR, McElhinny A (2025) Utilizing serum-derivef lipidomics with protein biomarkers and machine learning for early detection of ovarian cancer in the symptomatic population. Cancer Res Commun 5:1516\u20131529. https:\/\/doi.org\/10.1158\/2767-9764.CRC-25-0140","journal-title":"Cancer Res Commun"},{"issue":"13","key":"12848_CR47","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1182\/blood-2017-03-743211","volume":"130","author":"Y Hisada","year":"2018","unstructured":"Hisada Y, Mackman N (2018) Cancer-associated pathways and biomarkers of venous thrombosis. Blood 130(13):1499\u20131506. https:\/\/doi.org\/10.1182\/blood-2017-03-743211","journal-title":"Blood"},{"key":"12848_CR48","doi-asserted-by":"publisher","first-page":"640578","DOI":"10.3389\/fimmu.2021.640578","volume":"12","author":"L Shmied","year":"2021","unstructured":"Shmied L, Hoglund P, Meinke S (2021) Platelet-Mediated Protection of Cancer Cells from Immune Surveillance - Possible Implications for Cancer Immunotherapy. Front Immunol 12:640578. https:\/\/doi.org\/10.3389\/fimmu.2021.640578","journal-title":"Front Immunol"},{"key":"12848_CR49","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s10555-018-9755-8","volume":"37","author":"P Kanikarla-Marie","year":"2018","unstructured":"Kanikarla-Marie P, Kopetz S, Hawk ET, Milward SW, Sood AK, Gresele P, Overman M, Honn K, Menter DG (2018) Bioactive lipid metabolism in platelet first responder and cancer biology. Cancer Metastasis Rev 37:439\u2013454. https:\/\/doi.org\/10.1007\/s10555-018-9755-8","journal-title":"Cancer Metastasis Rev"},{"key":"12848_CR50","doi-asserted-by":"publisher","first-page":"106301","DOI":"10.1016\/j.phrs.2022.106301","volume":"182","author":"B Tesfamariam","year":"2022","unstructured":"Tesfamariam B, Wood SC (2022) Targeting glycoprotein VI to disrupt platelet-mediated tumor cell extravasation. Pharmacol Res 182:106301. https:\/\/doi.org\/10.1016\/j.phrs.2022.106301","journal-title":"Pharmacol Res"},{"key":"12848_CR51","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1038\/s41467-024-47516-w","volume":"15","author":"MJ Garcia-Leon","year":"2024","unstructured":"Garcia-Leon MJ, Liboni C, Mittelheisser V, Bochler L, Follain G, Mouriaux C, Busnelli I, Larnicol A, Colin F, Peralta M, Osmani N, Gensbittel V, Bourdon C, Samaniego R, Pichot A, Paul N, Molitor A, Carapito R, Jandrot-Perrus M, Lefebvre O, Mangin PH, Goetz J (2024) Platelets favor the outgrowth of established metastases. Nat Commun 15:3297. https:\/\/doi.org\/10.1038\/s41467-024-47516-w","journal-title":"Nat Commun"},{"issue":"1","key":"12848_CR52","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ygyno.2018.05.004","volume":"150","author":"T Baert","year":"2018","unstructured":"Baert T, Van Camp J, Van Brabant L, Busschaert P, Laenen A et al (2018) Influence of CA125, platelet count and neutrophil to lymphocyte ratio on the immune system of ovarian cancer patients. Gynecol Oncol 150(1):31\u201337. https:\/\/doi.org\/10.1016\/j.ygyno.2018.05.004","journal-title":"Gynecol Oncol"},{"issue":"2","key":"12848_CR53","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1182\/blood-2014-03-562538","volume":"124","author":"RJ Lin","year":"2014","unstructured":"Lin RJ, Afshar-Kharghan V, Sch\u00e4fer AI (2014) Paraneoplastic thrombocytosis: the secrets of tumor self-promotion. Blood 124(2):184\u2013187. https:\/\/doi.org\/10.1182\/blood-2014-03-562538","journal-title":"Blood"},{"key":"12848_CR54","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1152\/ajpheart.00212.2022","volume":"323","author":"E Hariri","year":"2022","unstructured":"Hariri E, Kakouros N, Bunsick DA, Russel SD, Mudd JO, Laws K, Lake MW, Rade J (2022) Nanoplatelets thromboxane generation is associated with impaired cardiovascular performance and mortality in heart failure. Am J Physiol Heart Circ Physiol 323:248\u2013255. https:\/\/doi.org\/10.1152\/ajpheart.00212.2022","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"12848_CR55","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.1200\/JCO.21.01900","volume":"40","author":"LM Hurwitz","year":"2022","unstructured":"Hurwitz LM, Townsend MK, Jordan SJ, Patel AV, Teras LR, Lacey JV Jr, Doherty JA, Harris HR, Goodman MT, Shvetsov YB, Modugno F, Moysich KB, Robien K, Prizment A, Schildkraut JM, Berchuck A, Fortner RT, Chan AT, Wentzensen N, Hartage P, Sandler DP, O\u2019Brien KM, Anton-Culver H, Ziogas A, Menon U, Ramus SJ, Pearce CL, Wu AH, White E, Peeters U, Webb PM, Tworoger SS, Trabert B (2022) Modification od the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-level Data From Two Ovarian Cancer Consortia. J Clin Oncol 40:4207\u20134217. https:\/\/doi.org\/10.1200\/JCO.21.01900","journal-title":"J Clin Oncol"},{"key":"12848_CR56","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.3390\/ijms27031288","volume":"27","author":"R Kanwal","year":"2026","unstructured":"Kanwal R, Jawed B, Zakir SK, GaudioF, Martinotti, Botteghi M, Martinotti S, Toniato E (2026) The Anti-Metastatic Role of Aspirin in Cancer: A Systematic Review. Int J Mol Sci 27:1288. https:\/\/doi.org\/10.3390\/ijms27031288","journal-title":"Int J Mol Sci"},{"key":"12848_CR57","doi-asserted-by":"publisher","first-page":"161546512","DOI":"10.3389\/fendo.2025.1546512","volume":"17","author":"M Hou","year":"2025","unstructured":"Hou M, Chu X, Wang S, Zhang Q, Ma M, Ma J (2025) The strategic role of lipidomics in biomarker identification and diagnosis of gynecological diseases. Front Endocrinol 17:161546512. https:\/\/doi.org\/10.3389\/fendo.2025.1546512","journal-title":"Front Endocrinol"},{"key":"12848_CR58","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1158\/1055-9965.EPI-23-1293","volume":"33","author":"S Sah","year":"2024","unstructured":"Sah S, Bifarin OO, Moore SG, Gaul DA, Chung H, Kwon SY, Cho H, Cho C, Kim J, Kim J, Fernandez FM (2024) Serum Lipidome Profiling Reveals a Sictinct Signature of Ovarian Cancer in Korean Women. Cancer Epidemiol Biomark Prev 33:681\u2013693. https:\/\/doi.org\/10.1158\/1055-9965.EPI-23-1293","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"9","key":"12848_CR59","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1136\/ijgc-2021-002951","volume":"31","author":"C Fotopoulou","year":"2021","unstructured":"Fotopoulou C, Planchamp F, Aytulu T, Chiva L, Cina A et al (2021) European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery. Int J Gynecol Cancer 31(9):1199\u20131206. https:\/\/doi.org\/10.1136\/ijgc-2021-002951","journal-title":"Int J Gynecol Cancer"},{"issue":"12","key":"12848_CR60","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1158\/1055-9965.epi-18-0203","volume":"27","author":"OB Akwinumi","year":"2018","unstructured":"Akwinumi OB, Babic A, Vitonis AF, Cramer DW, Titus L, Tworoger SS, Terry KL (2018) Chronic medical conditions and CA125 levels among women without ovarian cancer. Cancer Epidemiol Biomark Prev 27(12):1483\u20131490. https:\/\/doi.org\/10.1158\/1055-9965.epi-18-0203","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"12848_CR61","doi-asserted-by":"publisher","first-page":"188503","DOI":"10.1016\/j.bbcan.2021.188503","volume":"1875","author":"M Zhang","year":"2021","unstructured":"Zhang M, Cheng S, Jin Y, Zhao Y, Wang Y (2021) Roles of CA125 in diagnosis, prediction and oncogenesis of ovarian cancer. BBA Reviews Cancer 1875:188503. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188503","journal-title":"BBA Reviews Cancer"},{"issue":"1","key":"12848_CR62","doi-asserted-by":"publisher","first-page":"e22624","DOI":"10.1002\/jcla.22624","volume":"33","author":"B Kim","year":"2019","unstructured":"Kim B, Park Y, Kim B, Jun Ahn H, Lee K et al (2019) Diagnostic performance of CA125, HE4 and risk of ovarian malignancy algorithm for ovarian cancer. J Clin Lab Anal 33(1):e22624. https:\/\/doi.org\/10.1002\/jcla.22624","journal-title":"J Clin Lab Anal"},{"key":"12848_CR63","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.4049\/jimmunol.2000281","volume":"206","author":"RB Rowswel Turner","year":"2021","unstructured":"Rowswel Turner RB (2021) HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression. J Immunol 206:2478\u20132488. https:\/\/doi.org\/10.4049\/jimmunol.2000281","journal-title":"J Immunol"},{"key":"12848_CR64","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13048-019-0503-7","volume":"12","author":"V Dochez","year":"2019","unstructured":"Dochez V, Caillon H, Vaucel E, Dimet E, Dimet J et al (2019) Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA review. J Ovarian Res 12:28. https:\/\/doi.org\/10.1186\/s13048-019-0503-7","journal-title":"J Ovarian Res"},{"issue":"4","key":"12848_CR65","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/cncr.32582","volume":"126","author":"WL Yang","year":"2019","unstructured":"Yang WL, Lu Z, Guo J, Fellman BM, Ning J et al (2019) Human epididymis protein 4 antigen\u2013autoantibody complexes complement cancer antigen 125 for detecting early-stage ovarian cancer. Cancer 126(4):725\u2013736. https:\/\/doi.org\/10.1002\/cncr.32582","journal-title":"Cancer"},{"issue":"6","key":"12848_CR66","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.hoc.2018.07.003","volume":"32","author":"KM Elias","year":"2018","unstructured":"Elias KM, Guo J, Breast RC Jr (2018) Early detection of ovarian cancer. Hematol Oncol Clin N Am 32(6):903\u2013914. https:\/\/doi.org\/10.1016\/j.hoc.2018.07.003","journal-title":"Hematol Oncol Clin N Am"},{"issue":"5","key":"12848_CR67","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1097\/AOG.0000000000002580","volume":"131","author":"U Menon","year":"2018","unstructured":"Menon U, Karpinskyj C, Gentry-Maharaj A (2018) Ovarian cancer prevention and screening. Obstet Gynecol 131(5):909\u2013927. https:\/\/doi.org\/10.1097\/AOG.0000000000002580","journal-title":"Obstet Gynecol"},{"issue":"1","key":"12848_CR68","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3390\/ijms18010123","volume":"18","author":"A Horala","year":"2017","unstructured":"Horala A, Swiatly A, Matysiak J, Banach P, Nowak-Markwitz E, Kokot ZJ (2017) Diagnostic value of serum angiogenesis markers in ovarian cancer using multiplex immunoassay. Int J Mol Sci 18(1):123. https:\/\/doi.org\/10.3390\/ijms18010123","journal-title":"Int J Mol Sci"},{"key":"12848_CR69","doi-asserted-by":"publisher","first-page":"175883592412332","DOI":"10.1177\/17588359241233225","volume":"16","author":"A Ghose","year":"2024","unstructured":"Ghose A, McCann L, Makker S, Mukherjee U, Gullapallu SVN, Erekkath J, Shih S, Mahajan I, Sanchez E, Uccello M, Moschetta M, Adeleke S, Boussios S (2024) Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4. Therapeutic Adv Med Oncol 16:17588359241233225. https:\/\/doi.org\/10.1177\/17588359241233225","journal-title":"Therapeutic Adv Med Oncol"},{"key":"12848_CR70","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/s41416-021-01697-z","volume":"126","author":"T Mukama","year":"2022","unstructured":"Mukama T, Fortner RT, Katzke V, Hynes LC, Petrera A, Hauck SM, Johnson T, Schulze M, Schiborn C, Rostgaard-Hansen AL, Tjonneland A, Overvad JM, Perez S, Crous-Bou M, Chirlaque MD, Amiano P, Ardanaz E, Watt EL, Travis RC, Secerdote C, Grioni S, Masaa G, Signoriello S, Tumino R, Gram IT, Sandanger TM, Sartor H, Lundin E, Idahl A, Heath AK, Dossus L, Weiderpass E, Kaaks R Prospective evauation of 92 serum protein biomarkers for early detection of ovarian cancer. Br J Cancer (2022) ; 126:1301\u20131309. doi: https:\/\/doi.org\/10.1038\/s41416-021-01697-z","journal-title":"Br J Cancer"},{"issue":"5","key":"12848_CR71","doi-asserted-by":"publisher","first-page":"e0126444","DOI":"10.1371\/journal.pone.0126444","volume":"10","author":"ZH Hu","year":"2015","unstructured":"Hu ZH, Wei T, Yang M, Ma N, Tang Q et al (2015) Diagnostic value of osteopontin in ovarian cancer: a meta-analysis and systematic review. PLoS ONE 10(5):e0126444. https:\/\/doi.org\/10.1371\/journal.pone.0126444","journal-title":"PLoS ONE"},{"issue":"5","key":"12848_CR72","doi-asserted-by":"publisher","first-page":"264","DOI":"10.5694\/mja2.52227","volume":"220","author":"M Sideris","year":"2024","unstructured":"Sideris M, Menon U, Manchanda R (2024) Screening and prevention of ovarian cancer. Med J Austria 220(5):264\u2013274. https:\/\/doi.org\/10.5694\/mja2.52227","journal-title":"Med J Austria"},{"issue":"3","key":"12848_CR73","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3390\/diagnostics11030465","volume":"11","author":"GA Atallah","year":"2021","unstructured":"Atallah GA, Abd Aziz NH, Teik CK et al (2021) New predictive biomarkers for ovarian cancer. Diagnostics 11(3):465. https:\/\/doi.org\/10.3390\/diagnostics11030465","journal-title":"Diagnostics"},{"issue":"24","key":"12848_CR74","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.4103\/0366-6999.171459","volume":"128","author":"ZH Wang","year":"2015","unstructured":"Wang ZH, Xu CJ (2015) Research progress of microRNA in early detection of ovarian cancer. Chin Med J 128(24):3363\u20133370. https:\/\/doi.org\/10.4103\/0366-6999.171459","journal-title":"Chin Med J"},{"issue":"12","key":"12848_CR75","doi-asserted-by":"publisher","first-page":"6702","DOI":"10.3390\/ijms23126702","volume":"23","author":"DC Stieg","year":"2022","unstructured":"Stieg DC, Wang Y, Liu L, Jiang B (2022) ROS and miRNA dysregulation in ovarian cancer, development, angiogenesis and therapeutic resistance. Int J Mol Sci 23(12):6702. https:\/\/doi.org\/10.3390\/ijms23126702","journal-title":"Int J Mol Sci"},{"key":"12848_CR76","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1002\/jcp.26095","volume":"233","author":"B Deb","year":"2018","unstructured":"Deb B, Uddin A, Chakraborty S (2018) miRNAs and ovarian cancer: An overview. J Cell Physiol 233:3846\u20133854. https:\/\/doi.org\/10.1002\/jcp.26095","journal-title":"J Cell Physiol"},{"issue":"32","key":"12848_CR77","doi-asserted-by":"publisher","first-page":"e11505","DOI":"10.1097\/MD.0000000000011505","volume":"97","author":"M Shi","year":"2018","unstructured":"Shi M, Mu Y, Zhang H, Liu M, Wan J, Qin X, Li C (2018) MicroRNA-200 and microRNA-30 family as prognostic molecular signatures in ovarian cancer: a meta-analysis. Medicine 97(32):e11505. https:\/\/doi.org\/10.1097\/MD.0000000000011505","journal-title":"Medicine"},{"issue":"8","key":"12848_CR78","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3390\/biom14080928","volume":"14","author":"V Tavares","year":"2024","unstructured":"Tavares V, Savva-Bordalo J, Rei M, Liz-Pimenta J, Assis J et al (2024) Plasma microRNA environmental linked tissue factor pathway and cancer-associated thrombosis: prognostic significance in ovarian cancer. Biomolecules 14(8):928. https:\/\/doi.org\/10.3390\/biom14080928","journal-title":"Biomolecules"},{"issue":"1","key":"12848_CR79","doi-asserted-by":"publisher","first-page":"2373937","DOI":"10.1080\/01443615.2024.2373937","volume":"44","author":"H Lin","year":"2024","unstructured":"Lin H, Zhong W, Zhong L, Que C, Lin X (2024) The inflammatory markers combined with CA125 may predict postoperative survival in endometrial cancer. Journal Obstet Gynaecology 44(1):2373937. https:\/\/doi.org\/10.1080\/01443615.2024.2373937","journal-title":"Journal Obstet Gynaecology"},{"issue":"6","key":"12848_CR80","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ccell.2018.03.002","volume":"33","author":"M Haemmerle","year":"2019","unstructured":"Haemmerle M, Stone RL, Menter DG, Afshar-Kharghan V, Sood AK (2019) The platelet lifeline to cancer: challenges and opportunities. Cancer Cell 33(6):965\u2013983. https:\/\/doi.org\/10.1016\/j.ccell.2018.03.002","journal-title":"Cancer Cell"},{"key":"12848_CR81","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.plefa.2004.10.006","volume":"72","author":"MG Sciulli","year":"2005","unstructured":"Sciulli MG, Filabozzi P, Tacconelli S, Padovano R, Ricciotti E, Capone ML, Grana M, Carnevale V, Patrignani P (2005) Platelet activation in patients with colorectal cancer. Prostaglandin Leukotrienes Essent Fat Acids 72:79\u201383. https:\/\/doi.org\/10.1016\/j.plefa.2004.10.006","journal-title":"Prostaglandin Leukotrienes Essent Fat Acids"},{"key":"12848_CR82","doi-asserted-by":"publisher","unstructured":"Huang R, Li S, Guo H, Huang Y, Zhang X, Li M, Chen G, Zeng X (2014) Thromboxane A2 exerts promoting effects on cell proliferation through mediating cyclooxygenase-2 signal in lung adenocarcinoma cells. Journal of Cancer Research and Clinical Oncology 140:375\u2013386. https:\/\/doi.org\/10.1007\/s00432-013-1573-3","DOI":"10.1007\/s00432-013-1573-3"},{"key":"12848_CR83","doi-asserted-by":"publisher","unstructured":"Kij A, Kus K, Smeda M, Zakrzewska A, Proniewski B et al (2018) Differential effects of nitric oxide deficiency on primary tumour growth, pulmonary metastasis and prostacyclin\/thromboxane A2 balance in orthotopic and intravenous murine models of 4T1 breast cancer. Journal of Physiology and Pharmacology 69(6):911\u2013919. https:\/\/doi.org\/10.26402\/jpp.2018.6.05","DOI":"10.26402\/jpp.2018.6.05"},{"key":"12848_CR84","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3390\/molecules25020349","volume":"964","author":"M Puppolo","year":"2014","unstructured":"Puppolo M, Varma D, Jansen SA (2014) A review of analytical methods for eiconasoids in brain tissue. J Chromatogr B Analitycal Technol Biomedical Life Sciences 964:50\u201364. https:\/\/doi.org\/10.3390\/molecules25020349","journal-title":"J Chromatogr B Analitycal Technol Biomedical Life Sciences"},{"key":"12848_CR85","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jpba.2016.06.050","volume":"129","author":"A Kij","year":"2016","unstructured":"Kij A, Mateuszuk \u0141, Sitek B, Przyborowski K, Zakrzewska A, Wandzel KE et al (2016) Simultaneous quantification of PGI2 and TXA2 metabolites in plasma and urine in NO-deficient mice by a novel UHPLC\/MS\/MS method. J Pharm Biomedicinal Anal 129:148\u2013154. https:\/\/doi.org\/10.1016\/j.jpba.2016.06.050","journal-title":"J Pharm Biomedicinal Anal"},{"key":"12848_CR86","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000299085","volume":"18","author":"PK Heinonen","year":"1984","unstructured":"Heinonen PK, Metsa-KetelaT (1984) Prostaglandin and Thromboxane Prodution in Ovarian Cancer Tissue. Gynecol Obstet Invest 18:225\u2013229. https:\/\/doi.org\/10.1159\/000299085","journal-title":"Gynecol Obstet Invest"},{"key":"12848_CR87","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41416-023-02310-1","volume":"129","author":"N Joharatnam-Hogan","year":"2023","unstructured":"Joharatnam-Hogan N, Hatem D, Cafferty FH, Petrucci G, Cameron DA, Ring A, Kynaston HG, Gilbert DC, Wilson RH, Hubner RA, Swinson DEB, Cleary S, Robbins A, MacKenzie M, Scott-Brown MWG, Sothi S, Dawson LK, Capaldi LM, Chum M, Cunningham D, Khoo V, Armstrong AC, Ainsworth NL, Horan G, Wheatley DA, Mullen R, Lofts FJ, Walther A, Herbertson RA, Eaton JD, O\u2019Callaghan A, Eicholz A, Kagzi MM, Patterson DM, Harahari K, Bradbury J, Stokes Z, Rizvi AJ, Walker GA, Kunene VL, Srihari N, Gentry-Maharaj A, Maede A, Patrono R, Langley RE (2023) Thromboxane biosynthesis in cancer patients and its inhibition by asprin: a sub-study of the Add-Aspirin trial. Br J Cancer 129:706\u2013720. https:\/\/doi.org\/10.1038\/s41416-023-02310-1","journal-title":"Br J Cancer"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12848-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12848-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12848-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:42:07Z","timestamp":1790844127000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12848-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12848"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12848-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"assertion":[{"value":"22 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work the authors used ChatGPT in order to correct language imperfections. After using this tool\/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article.","order":3,"name":"Ethics","label":"Declaration of generative AI and AI-assisted technologies in the manuscript preparation process","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1664"}}